These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18998071)

  • 41. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors.
    Guichelaar MM; Schmoll J; Malinchoc M; Hay JE
    Hepatology; 2007 Oct; 46(4):1198-207. PubMed ID: 17654700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteoporosis across chronic liver disease.
    Guarino M; Loperto I; Camera S; Cossiga V; Di Somma C; Colao A; Caporaso N; Morisco F
    Osteoporos Int; 2016 Jun; 27(6):1967-77. PubMed ID: 26846777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osteoporosis in patients with primary biliary cirrhosis.
    Wariaghli G; Allali F; El Maghraoui A; Hajjaj-Hassouni N
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1397-401. PubMed ID: 20926953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bone disease in primary biliary cirrhosis].
    Shibata H; Nakao K
    Clin Calcium; 2015 Nov; 25(11):1633-8. PubMed ID: 26503867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment for hepatic osteodystrophy].
    Kaji H
    Clin Calcium; 2015 Nov; 25(11):1689-94. PubMed ID: 26503875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease.
    Guichelaar MM; Malinchoc M; Sibonga JD; Clarke BL; Hay JE
    J Bone Miner Res; 2003 Dec; 18(12):2190-9. PubMed ID: 14672354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
    Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
    Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Spontaneous fracture in chronic cholestasis. Hepatic osteopathy caused by vitamin D deficiency].
    Stiefelhagen P
    MMW Fortschr Med; 1999 Aug; 141(31-32):37-8. PubMed ID: 10766533
    [No Abstract]   [Full Text] [Related]  

  • 52. Bad to the bone: the effects of liver diseases on bone.
    Marignani M; Angeletti S; Capurso G; Cassetta S; Delle Fave G
    Minerva Med; 2004 Dec; 95(6):489-505. PubMed ID: 15785434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem.
    Carey EJ; Balan V; Kremers WK; Hay JE
    Liver Transpl; 2003 Nov; 9(11):1166-73. PubMed ID: 14586877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone mineral content in infants and children with chronic cholestatic liver disease.
    Argao EA; Specker BL; Heubi JE
    Pediatrics; 1993 Jun; 91(6):1151-4. PubMed ID: 8502519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Osteoporosis in liver cirrhosis].
    Guañabens N; Parés A
    Gastroenterol Hepatol; 2012; 35(6):411-20. PubMed ID: 22483016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Progress in diagnosis and therapy of extrahepatic manifestations of cholestatic liver diseases].
    Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):561-564. PubMed ID: 27788700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Alcohol-induced osteopenia].
    Keck E; Bremer G; Franck H
    Radiologe; 1986 Dec; 26(12):587-91. PubMed ID: 3823419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hepatic osteodystrophy].
    Suzuki K; Arakawa Y; Chino S; Yagi K
    Nihon Rinsho; 1998 Jun; 56(6):1604-8. PubMed ID: 9648489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pathophysiology of bone metabolism].
    Jakob F; Seefried L; Ebert R
    Internist (Berl); 2008 Oct; 49(10):1159-60, 1162, 1164 passim. PubMed ID: 18810375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Extrahepatic manifestations of liver diseases: skeleton].
    Leuschner U
    Praxis (Bern 1994); 2006 Oct; 95(40):1550-6. PubMed ID: 17048413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.